Global Progesterone Market Professional Survey Report 2016
- QYR584594
- 156 Pages
- May 2016
- Pharmaceuticals
Mainly covers the following product types
Injection
Freeze-dried powder
The segment applications including
Hospital use
Clinic
Household
Segment regions including (the separated region report can also be offered)
USA
China
UK
France
Switzerland
Japan
Germany
Canada
The players list (Partly, Players you are interested in can also be added)
Pfizer
Teva
Capsugel France
Novartis
Mylan
Squibb
Sandoz
Actavis, Inc
GSK
Mayne Pharma Inc
Merck Serono Europe Ltd
Abbott
Takeda
Fleet laboratories Limited
Shanghai General Pharmaceutical
Tianjin Kingyork Group
Guangzhou Baiyun Shan Ming Xing Pharmaceutical
Zhejiang Xianju Pharmaceutical
Zhejiang Asen Pharmacy Co., Ltd.
Galderma
With no less than 15 top producers.
Data including (both global and regions): Market Size (both volume - Bottle and value - million USD), Market Share, Production data, Consumption data, Trade data, Price - USD/Bottle, Cost, Gross margin etc.
More detailed information, please refer to the attachment file and table of contents. If you have other requirements, please contact us, we can also offer!
1 Industry Overview of Progesterone
1.1 Definition and Specifications of Progesterone
1.1.1 Definition of Progesterone
1.1.2 Specifications of Progesterone
1.2 Classification of Progesterone
1.2.1 Injection
1.2.2 Freeze-dried powder
1.3 Applications of Progesterone
1.3.1 Hospital use
1.3.2 Clinic
1.3.3 Household
1.4 Industry Chain Structure of Progesterone
1.5 Industry Overview and Major Regions Status of Progesterone
1.5.1 Industry Overview of Progesterone
1.5.2 Global Major Regions Status of Progesterone
1.6 Industry Policy Analysis of Progesterone
1.7 Industry News Analysis of Progesterone
2 Manufacturing Cost Structure Analysis of Progesterone
2.1 Raw Material Suppliers and Price Analysis of Progesterone
2.2 Equipment Suppliers and Price Analysis of Progesterone
2.3 Labor Cost Analysis of Progesterone
2.4 Other Costs Analysis of Progesterone
2.5 Manufacturing Cost Structure Analysis of Progesterone
2.6 Manufacturing Process Analysis of Progesterone
3 Technical Data and Manufacturing Plants Analysis of Progesterone
3.1 Capacity and Commercial Production Date of Global Progesterone Major Manufacturers in 2015
3.2 Manufacturing Plants Distribution of Global Progesterone Major Manufacturers in 2015
3.3 R&D Status and Technology Source of Global Progesterone Major Manufacturers in 2015
3.4 Raw Materials Sources Analysis of Global Progesterone Major Manufacturers in 2015
4 Global Progesterone Overall Market Overview
4.1 2011-2016E Overall Market Analysis
4.2.1 2011-2015 Global Progesterone Capacity and Growth Rate Analysis
4.2.2 2015 Progesterone Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 2011-2015 Global Progesterone Sales and Growth Rate Analysis
4.3.2 2015 Progesterone Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 2011-2015 Global Progesterone Sales Price
4.4.2 2015 Progesterone Sales Price Analysis (Company Segment)
4.5 Gross Margin Analysis
4.5.1 2011-2015 Global Progesterone Gross Margin
4.5.2 2015 Progesterone Gross Margin Analysis (Company Segment)
5 Progesterone Regional Market Analysis
5.1 USA Progesterone Market Analysis
5.1.1 USA Progesterone Market Overview
5.1.2 USA 2011-2016E Progesterone Local Supply, Import, Export, Local Consumption Analysis
5.1.3 USA 2011-2016E Progesterone Sales Price Analysis
5.1.4 USA 2015 Progesterone Market Share Analysis
5.2 China Progesterone Market Analysis
5.2.1 China Progesterone Market Overview
5.2.2 China 2011-2016E Progesterone Local Supply, Import, Export, Local Consumption Analysis
5.2.3 China 2011-2016E Progesterone Sales Price Analysis
5.2.4 China 2015 Progesterone Market Share Analysis
5.3 UK Progesterone Market Analysis
5.3.1 UK Progesterone Market Overview
5.3.2 UK 2011-2016E Progesterone Local Supply, Import, Export, Local Consumption Analysis
5.3.3 UK 2011-2016E Progesterone Sales Price Analysis
5.3.4 UK 2015 Progesterone Market Share Analysis
5.4 France Progesterone Market Analysis
5.4.1 France Progesterone Market Overview
5.4.2 France 2011-2016E Progesterone Local Supply, Import, Export, Local Consumption Analysis
5.4.3 France 2011-2016E Progesterone Sales Price Analysis
5.4.4 France 2015 Progesterone Market Share Analysis
5.5 Switzerland Progesterone Market Analysis
5.5.1 Switzerland Progesterone Market Overview
5.5.2 Switzerland 2011-2016E Progesterone Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Switzerland 2011-2016E Progesterone Sales Price Analysis
5.5.4 Switzerland 2015 Progesterone Market Share Analysis
5.6 Japan Progesterone Market Analysis
5.6.1 Japan Progesterone Market Overview
5.6.2 Japan 2011-2016E Progesterone Local Supply, Import, Export, Local Consumption Analysis
5.6.3 Japan 2011-2016E Progesterone Sales Price Analysis
5.6.4 Japan 2015 Progesterone Market Share Analysis
5.7 Germany Progesterone Market Analysis
5.7.1 Germany Progesterone Market Overview
5.7.2 Germany 2011-2016E Progesterone Local Supply, Import, Export, Local Consumption Analysis
5.7.3 Germany 2011-2016E Progesterone Sales Price Analysis
5.7.4 Germany 2015 Progesterone Market Share Analysis
5.8 Canada Progesterone Market Analysis
5.8.1 Canada Progesterone Market Overview
5.8.2 Canada 2011-2016E Progesterone Local Supply, Import, Export, Local Consumption Analysis
5.8.3 Canada 2011-2016E Progesterone Sales Price Analysis
5.8.4 Canada 2015 Progesterone Market Share Analysis
6 Global 2011-2016E Progesterone Segment Market Analysis (by Type)
6.1 Global 2011-2016E Progesterone Sales by Type
6.2 Different Types Progesterone Product Interview Price Analysis
6.3 Different Types Progesterone Product Driving Factors Analysis
6.3.1 Injection Progesterone Growth Driving Factor Analysis
6.3.2 Freeze-dried powder Progesterone Growth Driving Factor Analysis
7 Global 2011-2016E Progesterone Segment Market Analysis (by Application)
7.1 Global 2011-2016E Consumption by Application
7.2 Different Application Product Interview Price Analysis
7.3 Different Application Product Driving Factors Analysis
7.3.1 Hospital use Progesterone Growth Driving Factor Analysis
7.3.2 Clinic Progesterone Growth Driving Factor Analysis
7.3.3 Household Progesterone Growth Driving Factor Analysis
8 Major Manufacturers Analysis of Progesterone
8.1 Pfizer
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.3 Pfizer 2015 Progesterone Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 Pfizer 2015 Progesterone Business Region Distribution Analysis
8.2 Teva
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.3 Teva 2015 Progesterone Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 Teva 2015 Progesterone Business Region Distribution Analysis
8.3 Capsugel France
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.3 Capsugel France 2015 Progesterone Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 Capsugel France 2015 Progesterone Business Region Distribution Analysis
8.4 Novartis
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.3 Novartis 2015 Progesterone Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 Novartis 2015 Progesterone Business Region Distribution Analysis
8.5 Mylan
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.3 Mylan 2015 Progesterone Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 Mylan 2015 Progesterone Business Region Distribution Analysis
8.6 Squibb
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.3 Squibb 2015 Progesterone Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 Squibb 2015 Progesterone Business Region Distribution Analysis
8.7 Sandoz
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.3 Sandoz 2015 Progesterone Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.7.4 Sandoz 2015 Progesterone Business Region Distribution Analysis
8.8 Actavis, Inc
8.8.1 Company Profile
8.8.2 Product Picture and Specifications
8.8.3 Actavis, Inc 2015 Progesterone Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.8.4 Actavis, Inc 2015 Progesterone Business Region Distribution Analysis
8.9 GSK
8.9.1 Company Profile
8.9.2 Product Picture and Specifications
8.9.3 GSK 2015 Progesterone Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.9.4 GSK 2015 Progesterone Business Region Distribution Analysis
8.10 Mayne Pharma Inc
8.10.1 Company Profile
8.10.2 Product Picture and Specifications
8.10.3 Mayne Pharma Inc 2015 Progesterone Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.10.4 Mayne Pharma Inc 2015 Progesterone Business Region Distribution Analysis
8.11 Merck Serono Europe Ltd
8.11.1 Company Profile
8.11.2 Product Picture and Specifications
8.11.3 Merck Serono Europe Ltd 2015 Progesterone Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.11.4 Merck Serono Europe Ltd 2015 Progesterone Business Region Distribution Analysis
8.12 Abbott
8.12.1 Company Profile
8.12.2 Product Picture and Specifications
8.12.3 Abbott 2015 Progesterone Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.12.4 Abbott 2015 Progesterone Business Region Distribution Analysis
8.13 Takeda
8.13.1 Company Profile
8.13.2 Product Picture and Specifications
8.13.3 Takeda 2015 Progesterone Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.13.4 Takeda 2015 Progesterone Business Region Distribution Analysis
8.14 Fleet laboratories Limited
8.14.1 Company Profile
8.14.2 Product Picture and Specifications
8.14.3 Fleet laboratories Limited 2015 Progesterone Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.14.4 Fleet laboratories Limited 2015 Progesterone Business Region Distribution Analysis
8.15 Shanghai General Pharmaceutical
8.15.1 Company Profile
8.15.2 Product Picture and Specifications
8.15.3 Shanghai General Pharmaceutical 2015 Progesterone Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.15.4 Shanghai General Pharmaceutical 2015 Progesterone Business Region Distribution Analysis
8.16 Tianjin Kingyork Group
8.16.1 Company Profile
8.16.2 Product Picture and Specifications
8.16.3 Tianjin Kingyork Group 2015 Progesterone Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.16.4 Tianjin Kingyork Group 2015 Progesterone Business Region Distribution Analysis
8.17 Guangzhou Baiyun Shan Ming Xing Pharmaceutical
8.17.1 Company Profile
8.17.2 Product Picture and Specifications
8.17.3 Guangzhou Baiyun Shan Ming Xing Pharmaceutical 2015 Progesterone Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.17.4 Guangzhou Baiyun Shan Ming Xing Pharmaceutical 2015 Progesterone Business Region Distribution Analysis
8.18 Zhejiang Xianju Pharmaceutical
8.18.1 Company Profile
8.18.2 Product Picture and Specifications
8.18.3 Zhejiang Xianju Pharmaceutical 2015 Progesterone Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.18.4 Zhejiang Xianju Pharmaceutical 2015 Progesterone Business Region Distribution Analysis
8.19 Zhejiang Asen Pharmacy Co., Ltd.
8.19.1 Company Profile
8.19.2 Product Picture and Specifications
8.19.3 Zhejiang Asen Pharmacy Co., Ltd. 2015 Progesterone Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.19.4 Zhejiang Asen Pharmacy Co., Ltd. 2015 Progesterone Business Region Distribution Analysis
8.20 Galderma
8.20.1 Company Profile
8.20.2 Product Picture and Specifications
8.20.3 Galderma 2015 Progesterone Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.20.4 Galderma 2015 Progesterone Business Region Distribution Analysis
9 Development Trend of Analysis of Market
9.1 Global Market Trend Analysis
9.1.1 Global 2016-2021 Market Size (Volume and Value) Forecast
9.1.2 Global 2016-2021 Sales Price Forecast
9.1.3 Global 2016-2021 Gross Margin Forecast
9.2 Regional Market Trend
9.2.1 USA 2016-2021 Progesterone Consumption Forecast
9.2.2 China 2016-2021 Progesterone Consumption Forecast
9.2.3 UK 2016-2021 Progesterone Consumption Forecast
9.2.4 France 2016-2021 Progesterone Consumption Forecast
9.2.5 Switzerland 2016-2021 Progesterone Consumption Forecast
9.2.6 Japan 2016-2021 Progesterone Consumption Forecast
9.2.7 Germany 2016-2021 Progesterone Consumption Forecast
9.2.8 Canada 2016-2021 Progesterone Consumption Forecast
9.3 Market Trend (Product type)
9.4 Market Trend (Application)
10 Progesterone Marketing Model Analysis
10.1 Progesterone Regional Marketing Model Analysis
10.2 Progesterone International Trade Model Analysis
10.3 Traders or Distributors with Contact Information of Progesterone by Regions
10.4 Progesterone Supply Chain Analysis
11 Consumers Analysis of Progesterone
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis
…
12 New Project Investment Feasibility Analysis of Progesterone
12.1 New Project SWOT Analysis of Progesterone
12.2 New Project Investment Feasibility Analysis of Progesterone
13 Conclusion of the Global Progesterone Market Professional Survey Report 2016
Similar Reports
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
- Publish Date: November 14, 2017
- $5370
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
- Publish Date: July 20, 2017
- $5370
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...
- Publish Date: April 24, 2017
- $5370
